41 – 50 of 144
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.
(
- Contribution to journal › Article
-
Mark
The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma
(
- Contribution to journal › Article
- 2013
-
Mark
Origin of Swedish hemophilia B mutations
(
- Contribution to journal › Article
-
Mark
Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.
(
- Contribution to journal › Article
-
Mark
40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.
(
- Contribution to journal › Article
-
Mark
Measuring Oral Direct Inhibitors (ODIs) of thrombin and factor Xa : A recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis
(
- Contribution to journal › Article
- 2012
-
Mark
Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).
(
- Contribution to journal › Article
-
Mark
Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
(
- Contribution to journal › Letter
-
Mark
Origin of Swedish hemophilia A mutations
(
- Contribution to journal › Article